These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10229631)

  • 1. Structure-activity relationships of bisphosphate nucleotide derivatives as P2Y1 receptor antagonists and partial agonists.
    Nandanan E; Camaioni E; Jang SY; Kim YC; Cristalli G; Herdewijn P; Secrist JA; Tiwari KN; Mohanram A; Harden TK; Boyer JL; Jacobson KA
    J Med Chem; 1999 May; 42(9):1625-38. PubMed ID: 10229631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biological activity, and molecular modeling of ribose-modified deoxyadenosine bisphosphate analogues as P2Y(1) receptor ligands.
    Nandanan E; Jang SY; Moro S; Kim HO; Siddiqui MA; Russ P; Marquez VE; Busson R; Herdewijn P; Harden TK; Boyer JL; Jacobson KA
    J Med Chem; 2000 Mar; 43(5):829-42. PubMed ID: 10715151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deoxyadenosine bisphosphate derivatives as potent antagonists at P2Y1 receptors.
    Camaioni E; Boyer JL; Mohanram A; Harden TK; Jacobson KA
    J Med Chem; 1998 Jan; 41(2):183-90. PubMed ID: 9457242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acyclic analogues of deoxyadenosine 3',5'-bisphosphates as P2Y(1) receptor antagonists.
    Kim YC; Gallo-Rodriguez C; Jang SY; Nandanan E; Adams M; Harden TK; Boyer JL; Jacobson KA
    J Med Chem; 2000 Feb; 43(4):746-55. PubMed ID: 10691699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acyclic and cyclopropyl analogues of adenosine bisphosphate antagonists of the P2Y1 receptor: structure-activity relationships and receptor docking.
    Kim HS; Barak D; Harden TK; Boyer JL; Jacobson KA
    J Med Chem; 2001 Sep; 44(19):3092-108. PubMed ID: 11543678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methanocarba modification of uracil and adenine nucleotides: high potency of Northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors.
    Kim HS; Ravi RG; Marquez VE; Maddileti S; Wihlborg AK; Erlinge D; Malmsjö M; Boyer JL; Harden TK; Jacobson KA
    J Med Chem; 2002 Jan; 45(1):208-18. PubMed ID: 11754592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Substitution of adenine nucleotide analogues containing a bicyclo[3.1.0]hexane ring system locked in a northern conformation: enhanced potency as P2Y1 receptor antagonists.
    Kim HS; Ohno M; Xu B; Kim HO; Choi Y; Ji XD; Maddileti S; Marquez VE; Harden TK; Jacobson KA
    J Med Chem; 2003 Nov; 46(23):4974-87. PubMed ID: 14584948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenine nucleotide analogues locked in a Northern methanocarba conformation: enhanced stability and potency as P2Y(1) receptor agonists.
    Ravi RG; Kim HS; Servos J; Zimmermann H; Lee K; Maddileti S; Boyer JL; Harden TK; Jacobson KA
    J Med Chem; 2002 May; 45(10):2090-100. PubMed ID: 11985476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acyclic analogues of adenosine bisphosphates as P2Y receptor antagonists: phosphate substitution leads to multiple pathways of inhibition of platelet aggregation.
    Xu B; Stephens A; Kirschenheuter G; Greslin AF; Cheng X; Sennelo J; Cattaneo M; Zighetti ML; Chen A; Kim SA; Kim HS; Bischofberger N; Cook G; Jacobson KA
    J Med Chem; 2002 Dec; 45(26):5694-709. PubMed ID: 12477353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of potent, selective P2Y-purinoceptor agonists: structure-activity relationships for 2-thioether derivatives of adenosine 5'-triphosphate.
    Fischer B; Boyer JL; Hoyle CH; Ziganshin AU; Brizzolara AL; Knight GE; Zimmet J; Burnstock G; Harden TK; Jacobson KA
    J Med Chem; 1993 Nov; 36(24):3937-46. PubMed ID: 8254622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competitive and selective antagonism of P2Y1 receptors by N6-methyl 2'-deoxyadenosine 3',5'-bisphosphate.
    Boyer JL; Mohanram A; Camaioni E; Jacobson KA; Harden TK
    Br J Pharmacol; 1998 May; 124(1):1-3. PubMed ID: 9630335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of novel agonist selectivity for the ADP-activated P2Y1 receptor versus the ADP-activated P2Y12 and P2Y13 receptors by conformational constraint of an ADP analog.
    Chhatriwala M; Ravi RG; Patel RI; Boyer JL; Jacobson KA; Harden TK
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1038-43. PubMed ID: 15345752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Chloro N(6)-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate is a selective high affinity P2Y(1) receptor antagonist.
    Boyer JL; Adams M; Ravi RG; Jacobson KA; Harden TK
    Br J Pharmacol; 2002 Apr; 135(8):2004-10. PubMed ID: 11959804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of pyridoxal phosphate derivatives as potent and selective antagonists of P2X1 receptors.
    Kim YC; Brown SG; Harden TK; Boyer JL; Dubyak G; King BF; Burnstock G; Jacobson KA
    J Med Chem; 2001 Feb; 44(3):340-9. PubMed ID: 11462975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pyridoxine cyclic phosphate and its 6-azoaryl derivative selectively potentiate and antagonize activation of P2X1 receptors.
    Jacobson KA; Kim YC; Wildman SS; Mohanram A; Harden TK; Boyer JL; King BF; Burnstock G
    J Med Chem; 1998 Jun; 41(13):2201-6. PubMed ID: 9632352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of competitive antagonists of the P2Y1 receptor.
    Boyer JL; Romero-Avila T; Schachter JB; Harden TK
    Mol Pharmacol; 1996 Nov; 50(5):1323-9. PubMed ID: 8913364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of the P2Y(1) receptor with a high affinity radiolabeled antagonist.
    Waldo GL; Corbitt J; Boyer JL; Ravi G; Kim HS; Ji XD; Lacy J; Jacobson KA; Harden TK
    Mol Pharmacol; 2002 Nov; 62(5):1249-57. PubMed ID: 12391289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of selective high affinity antagonists, agonists, and radioligands for the P2Y1 receptor.
    Houston D; Costanzi S; Jacobson KA; Harden TK
    Comb Chem High Throughput Screen; 2008 Jul; 11(6):410-9. PubMed ID: 18673269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human P2Y1 receptor: molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites.
    Moro S; Guo D; Camaioni E; Boyer JL; Harden TK; Jacobson KA
    J Med Chem; 1998 Apr; 41(9):1456-66. PubMed ID: 9554879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structurally related nucleotides as selective agonists and antagonists at P2Y1 receptors.
    Jacobson KA; Moro S; Hoffmann C; Kim YC; Kim HS; Ravi RG; Harden TK; Boyer JL
    Farmaco; 2001; 56(1-2):71-5. PubMed ID: 11347970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.